Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: J Hepatol. 2014 Nov 27;62(4):841–847. doi: 10.1016/j.jhep.2014.11.024

Table 2.

Adjusted Odds Ratios (95% Confidence Intervals) of elevated hs-troponin T and elevated NT-proBNP by quartiles of liver enzymes

Model 1
OR (95% CI)
Model 2
OR (95% CI)
Model 3
OR (95% CI)
Elevated hs-troponin T (>14 ng/L)
ALT
 Q1 1 (Reference) 1 (Reference) 1 (Reference)
 Q2 1.01 (0.77–1.34) 1.01 (0.76–1.33) 1.02 (0.76–1.36)
 Q3 0.96 (0.73–1.27) 0.96 (0.73–1.27) 0.95 (0.71–1.26)
 Q4 1.54 (1.20–1.99) 1.54 (1.19–1.99) 1.46 (1.12–1.91)
AST
 Q1 1 (Reference) 1 (Reference) 1 (Reference)
 Q2 0.76 (0.57–1.01) 0.75 (0.56–1.01) 0.92 (0.68–1.25)
 Q3 0.94 (0.70–1.24) 0.93 (0.70–1.24) 1.19 (0.87–1.61)
 Q4 1.37 (1.05–1.78) 1.36 (1.05–1.78) 1.72 (1.30–2.29)
GGT
 Q1 1 (Reference) 1 (Reference 1 (Reference)
 Q2 1.44 (1.06–1.94) 1.44 (1.07–1.96) 1.33 (0.97–1.82)
 Q3 1.36 (1.00–1.84) 1.37 (1.01–1.86) 1.14 (0.83–1.58)
 Q4 1.84 (1.38–2.48) 1.86 (1.39–2.50) 1.44 (1.05–1.97)

Elevated NT-proBNP (>400 pg/mL)
ALT
 Q1 1 (Reference) 1 (Reference) 1 (Reference)
 Q2 0.71 (0.53–0.97) 0.74 (0.54–1.01) 0.81 (0.59–1.12)
 Q3 0.53 (0.38–0.74) 0.57 (0.40–0.79) 0.64 (0.45–0.92)
 Q4 0.40 (0.28–0.58) 0.44 (0.30–0.63) 0.49 (0.33–0.72)
AST
 Q1 1 (Reference) 1 (Reference) 1 (Reference)
 Q2 0.82 (0.58–1.14) 0.86 (0.61–1.20) 0.94 (0.66–1.35)
 Q3 0.79 (0.56–1.12) 0.87 (0.61–1.23) 0.92 (0.63–1.33)
 Q4 0.58 (0.40–0.83) 0.64 (0.45–0.93) 0.67 (0.46–0.99)
GGT
 Q1 1 (Reference) 1 (Reference) 1 (Reference)
 Q2 0.70 (0.49–0.99) 0.68 (0.48–0.97) 0.73 (0.51–1.06)
 Q3 1.03 (0.73–1.45) 1.04 (0.74–1.46) 1.15 (0.80–1.65)
 Q4 0.95 (0.68–1.34) 0.96 (0.69–1.37) 0.98 (0.67–1.43)

Model 1: age (years), race-center, sex, education (less than high school, high school, college or above)

Model 2: variables in Model 1 + smoking (current, former, or never smoker), alcohol consumption (current, former, or never drinker)

Model 3: variables in Model 2+ body mass index (kg/m2), systolic blood pressure (mm/Hg), diastolic blood pressure (mm/Hg), fasting glucose (mg/dL), LDL (mg/dL) and HDL-cholesterol (mg/dL), hypertension medication use, C-reactive protein (mg/L) and eGFR (mL/min/1.73m2)

HHS Vulnerability Disclosure